Evidence from cross-sectional studies was corroborated in intervention studies: Gut microbiome transfer from healthy subjects into patients with T2D resulted in a significant improvement in insulin sensitivity over a period of six weeks [32,33]. This evidence concerns the gene INS and type 2 diabetes mellitus.